Alpha Synuclein pSer129 Monomers
Produktgrößen
100 ug
£765,00
SPR-520-100UG
2 x 100 ug
£1149,00
SPR-520-2X100UG
500 ug
£2240,00
SPR-520-500UG
Über dieses Produkt
- SKU:
- SPR-520
- Zusätzliche Namen:
- Alpha-synuclein, Alpha synuclein, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor, NACP, SNCA, PARK1, SYN, PD1, PARK4, Synuclein Alpha, Alpha Synuclein pSer129, Asyn
- Anwendung:
- Cell-based/Functional Assay, SDS-PAGE, Western Blot
- Buffer:
- PBS
- CE/IVD:
- RUO
- Weitere Details:
- Alpha-synuclein (A Alpha-synuclein), encoded by the SNCA gene, is a neuronal protein involved in synaptic vesicle trafficking, neurotransmitter release, and SNARE-complex assembly. In neurodegenerative diseases such as Parkinson's disease, A Alpha-synuclein undergoes pathological modifications, with phosphorylation at serine 129 (pSer129) being the most prominent post-translational change observed in aggregated forms within Lewy bodies. Phosphorylated A Alpha-synuclein at Ser129 is considered a biomarker of disease-associated aggregation and neurotoxicity. Monomeric pSer129 A Alpha-synuclein allows researchers to isolate and study the functional consequences of this specific modification. These monomers exhibit altered conformational dynamics, aggregation propensity, and cellular interactions compared to their non-phosphorylated counterparts. In neurodegenerative disease models, pSer129 monomers are used to investigate early misfolding events, membrane binding behavior, and the role of phosphorylation in promoting toxic oligomer formation. Their application supports mechanistic studies on synaptic dysfunction, mitochondrial impairment, and neuroinflammatory signaling pathways. Alpha-synuclein pSer129 monomers are also valuable in therapeutic screening platforms, enabling the evaluation of compounds that target phosphorylation-dependent aggregation or enhance clearance of modified A Alpha-synuclein. By replicating disease-relevant molecular features, these monomers accelerate translational research aimed at understanding and mitigating the progression of Parkinson's disease and related synucleinopathies. StressMarq's Alpha Synuclein Ser129 Monomers are generated in-house and phosphorylation confirmed with our anti-ASYN pS129 monoclonal antibody (catalog# SMC-600).
- Immunogen:
- Alpha Synuclein pSer129 Monomers
- Molekulargewicht:
- 14.46 kDa
- Reinheit:
- >95%
- Aufreinigung:
- Ion Exchange
- Sequenz:
- MDVFMKGLSK AKEGVVAAAE KTKQGVAEAA GKTKEGVLYV GSKTKEGVVH GVATVAEKTK EQVTNVGGAV VTGVTAVAQK TVEGAGSIAA ATGFVKKDQL GKNEEGAPQE GILEDMPVDP DNEAYEMPSE EGYQDYEPEA
- Versandbedingungen:
- Dry Ice
- Lagerbedingungen:
- -70[o]C
- Hersteller:
- StressMarq Biosciences
- Typ:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Recombinant Proteins
- Datenblatt des Herstellers:https://www.stressmarq.com/products/protein/alpha-synuclein-pser129-monomers-spr-520/